The following useful discussion appeared a few days ago
The quest for value
By Nancy Ferris
Peter Orszag, an economist and director of the Congressional Budget Office, has a high-deductible health insurance plan and a health savings account. But making those purchasing decisions wasn’t easy, he said.
“It is often difficult as a nonmedical professional to determine what is or is not valuable,” Orszag recently told the House Budget Committee.
Experts are struggling to make the same determinations about health information technology. As part of its mission to attach a dollar value to every bill Congress acts on, CBO issued a report in May questioning the value of health IT.
“No aspect of health IT entails as much uncertainty as the magnitude of its potential benefits,” the report states.
Although health IT could enable changes to U.S. health care, it has little value on its own, Orszag said. Without other reforms, “it doesn’t generate the kind of results many people would hope for,” he added.
CBO’s report questioned an often-quoted 2005 Rand study that estimated the value of health IT to be $80 billion in annual savings once 90 percent of hospitals and doctors adopt it. CBO took issue with Rand’s methodology and conclusions.
Lead researcher Richard Hillestad has appeared before Congress several times to defend the Rand study. He said the $80 billion savings level might be delayed for 10 to 15 years based on the slow rate of health IT adoption, but he stuck with the estimate.
However, he added, “the potential savings we calculate are spread among stakeholders — insurers or payers, providers, and individuals — so such savings are not necessarily savings the government might realize from programs to enhance the adoption” of health IT.
Orszag and Hillestad agreed on one thing: In Hillestad’s words, “The broad adoption of [health IT] systems and connectivity should be considered necessary but not sufficient steps toward real health care transformation that delivers efficient and effective care at the right time.”
In other words, health IT could be the basis for desired changes in health care.
A public good? That’s something many state and federal policy-makers have begun to recognize. Sen. Max Baucus (D-Mont.), chairman of the Senate Finance Committee, said last month, “Health IT adoption is likely to be a key component of health care reform.”
But he and others continue to wrestle with questions of who will benefit from health IT and who should pay for it. Some experts are urging them to view health IT as a public good, comparable to the interstate highway system or state universities.
“The financial benefits…may be very large, but many of the benefits may accrue to society,” said Dr. David Westfall Bates, medical director of clinical and quality analysis at Partners HealthCare System in Boston.
CBO endorsed the concept in its report, stating: “The technology has some characteristics of a public good — that is, a good that would be provided in a less-than-optimal amount by private markets if the government did not intervene.”
Much more here:
http://www.govhealthit.com/blogs/ghitnotebook/350530-1.html
Nancy Ferris also provides some useful additional information here with a range of sidebar lists.
http://www.govhealthit.com/print/4_20/features/350520-1.html
Peter Orszag from the Congressional Budget Office (CBO) has had a long interest in health care costs.
See:
http://aushealthit.blogspot.com/2008/02/useful-and-interesting-health-it-links_10.html
and
http://aushealthit.blogspot.com/2008/06/useful-and-interesting-health-it-links_22.html
The report being discussed is found here:
http://www.cbo.gov/ftpdocs/91xx/doc9168/HealthITTOC.2.1.htm
The core point in this discussion relates to the distribution of benefits when Health IT is purchased and implemented. Sadly those who incur most of the expenses are not those who receive direct benefits – hence the argument that Health IT does not provide good value.
However, if the total impact of Health IT is assessed that argument simply does not stack up. Read the long blog entry for the details. It is important to understand the value linkages in this domain to put coherent arguments for adoption.
The following paragraphs from late in the second Ferris article make this point clearly.
“That failure to get the ROI relates very clearly to my losing my job,” Mingle said. Officials reorganized the IT staff and eliminated his position, and though they offered him another job, he chose not to accept it.
“There’s a belief that you install a system like this and the ROI accrues to you passively,” Mingle said. “It doesn’t. It’s not a passive thing.”
“To really make it work, you have to start handling your patients differently, start handing off your work to one another differently, and even redistributing the work among the people there and building new skills in the people there,” he said. “And if you don’t do that, those key returns on investment become elusive.”
Orszag made a similar point, although he was speaking as an economist assessing the big picture. “If you just plop a health IT system down in the middle of a fragmented [health care] system, with financial incentives that encourage more care rather than better care and without a system for using the information that is coming out of the health IT structure to improve quality, you are not going to get very much,” he said.”
The basic truth is that pure cash based ROI is not the way to think of health IT. It is the process, quality and safety benefits – which are non-cash – that really matter and which save lives. The mix of cash neutral and additional quality and safety makes Health IT a no-brainer.
The concept of a ‘value case’ rather than a pure business case is where our thinking now needs to be!
Two useful efforts indeed!
David.
1 comment:
The Casemix Conference in November should provide a useful discussion of Health IT. My superficial take on Casemix is that 'occasions of care' in public hospitals are funded according to agreed formulae. As I understand it, this is in contrast to the situation in the private system where everything is paid for on an item, or transaction, basis.
The private system seems to resent any homogenisation of payment moieties, usually blackguarding them as "US-style Managed Care".
The AMA spokesperson said as much in response to Bonus plan to help fight superbugs:
Ms Roxon said private hospitals would have to release information about performance indicators including death, infection and readmission rates. If her plan takes effect, Medibank intends to write an incentive clause into its contracts with private hospitals, paying extra if they can show decreasing infection rates or implement new infection prevention systems.
At the heart of this proposal is the perverse incentive for the private system to reimburse, at standard rates, any service required to treat a complication. This question could be on the agenda at a Safety & Quality conference in October (Adverse Events in Australian Hospitals: At what cost?).
In the case of post-operative infections, good IT is paramount. VPAC has collaborated with an infection control agency to produce surveillance software. I'd be very interested to know how their program tracks specific micro-organisms down through the depths of the different nomenclatures. That's also the question I have put to NEHTA's ePathology domain. Still waiting.
Post a Comment